News

US FDA approves Insmed's drug as first treatment for a chronic lung disease
The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday ...
US FDA approves Insmed's lung disease drug
The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday ...
Curry recall in 33 states as FDA issues risk warning
Jagpreet Enterprises LLC issued a voluntary recall for four products on July 23 due to potential metal contamination.
A Giant Indian Drugmaker Failed to Fix Safety Breaches. The FDA Let It Off the Hook Again and Again.
Documents obtained by ProPublica offer a rare glimpse into discussions between the global drugmaker Sun Pharma and the FDA, ...
The FDA Let Substandard Factories Ship These Medications to the U.S.
ProPublica identified more than 150 products that were exempted from import bans since 2013. Our list provides the names of ...
Ousted FDA vaccine regulator Vinay Prasad returns to post
Vinay Prasad, the U.S. Food and Drug Administration's top vaccine regulator, is returning to his post less than two weeks ...
Medpage Today on MSN21h
Ousted FDA Vaccine Chief Vinay Prasad Is Returning to the Agency
Vinay Prasad, MD, MPH, is resuming leadership of the FDA center that regulates vaccines and biotech therapies, an HHS ...
Laura Loomer Blasts Return of FDA Vaccine Chief She Helped Force Out
Loomer is an influential figure in right-wing circles. She was present alongside Trump on the 2024 campaign trail, and she ...
Vinay Prasad returns to role as top vaccine regulator at FDA days after leaving US agency
Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S. Food and Drug ...
FDA Approves Ajovy for Migraine Prevention in Children and Teens
By Lori Solomon HealthDay ReporterMONDAY, Aug. 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
FDA official returns to agency after Loomer-led ouster
Dr. Vinay Prasad, a controversial critic of the US Food and Drug Administration who took a top role at the regulatory agency ...